What does City Hill Ventures invest in?
City Hill Ventures invests most often at Series A and Series B (67% of the rounds on record), in sectors such as Medical, Medical Device and Health Care.

United States · Investor
Last cheque observed Sep 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
VC firmQuiet
Follow City Hill Ventures and see its new cheques in your feed. Start following
9 rounds on record
Mostly Series A and Series B: 67% of its rounds
Sole investor in 3 rounds, median $5.0M
City Hill is an impact-minded investment firm launched in 2010 that founds, funds and leads mission-driven for-profit and non-profit initiatives.From their own website
Every round we can evidence, newest first9 appearances
2 rounds
2 rounds
1 round
1 round
2 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From their own portfolio page (on their website)
Black Diamond TherapeuticsBoundless BioErasca (IPO inIndependaORIC Pharmaceuticals (IPOIgnyta (acquired byNovaBay Pharmaceuticals (PIPEOpus 12RespivantSana Biotechnology (IPOStampede Ventures
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as City Hill Ventures. A count of rooms they were both in, not a relationship either has claimed.
The latest companies City Hill Ventures put money into.
City Hill Ventures invests most often at Series A and Series B (67% of the rounds on record), in sectors such as Medical, Medical Device and Health Care.
9 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Sept 2019.
Its most recent investments on record: Boundless Bio (Series A, Sept 2019), OncoMyx Therapeutics (Series A, Jun 2019) and Erasca (Series A, Dec 2018).
The median round it joins is $34M.
Sometimes: it led 1 of its 9 investments on record (11%).
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Sept 2019.
Most often Miramar Ventures (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it